Back to News
Market Impact: 0.08
SAN FRANCISCO HEALTH PLAN EARNS HISTORIC 4.5-STAR RATING IN 2026 NCQA HEALTH PLAN RATINGS
Source: PR Newswire
Healthcare & Biotech
San Francisco Health Plan received its first-ever 4.5-star rating in the 2026 NCQA Health Plan Ratings as it approaches 30 years of community service. The achievement signals improved healthcare-plan quality and member-service performance, but is unlikely to have material public-market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
More News
- Illumina CEO on Q3 Results and Business Outlook
- UnitedHealth is finally getting its act together. I'm buying into the turnaround
- Swiss Firms Plan Investment Boost in China Drug, Finance Sectors
- Bernstein SocGen raises Eli Lilly stock price target on strong Q3 beat
- Freedom Broker raises Eli Lilly stock price target on GLP-1 demand
- Regeneron Q3 revenue tops estimates on Sanofi Dupixent profit; shares rise 4%